–
New Buy Entry Alert RAP
Time Frame : Daily/Weekly
Sector : Healthcare Equipment and Services
Key Stats : $110.9 Million Market Cap, VWAP 0.175, ASX Ranking 718, 4 Week Av Turnover $158,959, Current Turnover (Intraday as at time of alert) $166,682.
Company Overview : ResApp Health Limited (RAP, formerly Narhex Life Sciences Limited) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware.
Broker Consensus : BUY
–
RAP – Resapp Health Limited
RAP is holding higher levels as buyers support price and build for a run up through the recent highs at 0.20. We are happy to buy at 0.175 (current buy level) and will hold a stop loss at 0.15. Watching now for buyers to chew away at 0.18 to take out the lower high.
Stock Code : RAP – Resapp Health Limited
Company Website : www.resapphealth.com.au
Current Price : 0.175
New Potential Buy Entry (Trigger Level) : 0.175
Potential Sell Exit Zone (Stop Loss) : 0.15
Status : On watch for buy entry trigger
